Funding Opportunity PAR-21-241 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research priority. Applications submitted under this FOA are expected to propose a multi-site clinical trial to assess whether the intervention can be delivered with fidelity across sites; demonstrate feasibility of recruitment, accrual, and randomization of participants across sites; demonstrate participant adherence to the intervention, as well as retention of participants throughout the study across sites; and/or demonstrate feasibility of data collection across sites in preparation for a future multi-site trial. The need for multi-site feasibility trials are expected to be justified by sufficient preliminary data from previous single site feasibility or acceptability trial(s)or the published literature. This FOA will not support randomized clinical trials to determine efficacy or effectiveness. The data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive fully powered multi-site clinical trial that has the potential to make a significant impact on public health Applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this FOA..

Funding Opportunity PAR-21-240 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity is to support early phase clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high priority research topics. This funding opportunity is intended to support feasibility clinical trials, which will provide data that are critical for the planning and design of a subsequent controlled cohort study, clinical efficacy or effectiveness study, or a pragmatic trial. The data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial, including, but not limited to the following: examining feasibility and acceptability of interventions lacking published data; adapting an intervention to a specific population; refining the intervention to determine the most appropriate frequency or duration; determining feasibility of recruitment, retention and data collection procedures; refining and assessing the feasibility of protocolized multimodal interventions; or examining acceptability and adherence of control conditions. This FOA will not support randomized clinical trials to test or determine efficacy or effectiveness; nor will this FOA support repetition of feasibility or acceptability research that has been previously conducted in the same or similar patient population with the same or similar intervention. Applications that propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial are not appropriate for this announcement. The subsequent larger trial should have the potential to make a significant impact on public health.

GBP50000.00 - GBP60000.00 per annum: SRG: Assay Development - NGS Oxfordshire, England

Conduct analysis and procedures to improve scientific understanding and presentation of the relationships among genetic and genomic parameters and dairy… $53,433 - $84,049 a year
From usajobs.gov - Fri, 11 Jun 2021 15:46:51 GMT - View all Madison, WI jobs

Notice NOT-DC-21-003 from the NIH Guide for Grants and Contracts

GBP20000.00 - GBP30000.00 per annum: SRG: Biochemistry Associate Scientist Oxfordshire, England

Notice NOT-DC-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-HS-21-016 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-265 from the NIH Guide for Grants and Contracts

Up to GBP17.28 per hour + + 20% Uplift for Nights: SRG: We are looking for Data Scientists to join NHS Test and Trace team in Leamington Spa. Leamington Spa, England

Up to GBP17.28 per hour + + 20% Uplift for Nights: SRG: We are looking for Data Scientists to join NHS Test and Trace team in Leamington Spa. Leamington Spa, England

Funding Opportunity RFA-AG-22-014 from the NIH Guide for Grants and Contracts. The goal of this Research and Entrepreneurial Development Immersion (REDI) Small Business Technology Transfer Research (STTR) Grant is to foster the career development of early career scientists with an interest in entrepreneurship by simultaneously supporting their entrepreneurial development and facilitating their transition to industry.

Funding Opportunity RFA-AG-22-007 from the NIH Guide for Grants and Contracts. The goal of this Research and Entrepreneurial Development Immersion (REDI) Small Business Innovation Research (SBIR) Grant is to foster thecareer development of early-career scientists with an interest in entrepreneurship by simultaneously supporting their entrepreneurial development and facilitating their transition to industry.

Funding Opportunity RFA-AG-22-004 from the NIH Guide for Grants and Contracts. The purpose of the NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence.

Funding Opportunity RFA-AG-22-003 from the NIH Guide for Grants and Contracts. The purpose of the Research and Entrepreneurial Development Immersion (REDI): NIA Entrepreneurship Enhancement Award (R25) is to promote the development of entrepreneurial training programs that are designed to broaden the skillset of graduate students and postdocs, as well as early career master's, Ph.D., and Dr.P.H. scientists, in fields relevant to the mission of NIA, including aging and Alzheimer's disease (AD) research. The goal of this program is to prepare trainees for a wide range of career paths, including those that are outside the normal research environment.

Funding Opportunity PAR-21-244 from the NIH Guide for Grants and Contracts. The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or vulnerability to distinct stages along the substance use disorder (SUD) trajectory (e.g. initial/acute use, escalation of use, acquisition of tolerance, dependence, uncontrolled use, abstinence and relapse or recovery); 2. Behaviors associated with SUD (e.g. impulsivity, novelty seeking, delayed discounting, and other genetically-associated phenotypes); and 3. Comorbidities that demonstrate genetic correlations with phenotypes and behaviors linked with SUD (e.g. anxiety, stress, poor maternal care, social defeat, and other paradigms). Applications may examine any type of variant, including single nucleotide variants (SNVs), indels, large and small structural variants, and all types of mobile DNA. NIDA encourages applications that take genomics, multi-omics, and/or data-based approaches that integrate multi-level omics data, delineate gene networks, and/or uncover the function of known or newly discovered genetic or epigenetic variants. NIDA expects these studies to uncover novel mechanisms that contribute to SUD and facilitate the discovery of targets for intervention and guide the development of individualized therapeutics to treat these different aspects of SUD.

Funding Opportunity RFA-AI-21-046 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate fundamental research of human disease-causing pathogens in the Bunyavirales order by supporting projects studying vector competence, virology, pathogenesis, and immunity.

Funding Opportunity RFA-AG-22-019 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will use the R01 funding mechanism to support discrete, specified, and circumscribed projects on novel molecular imaging approaches to establish high-resolution mapping of biomolecules in brain cells and regions during the course of aging and Alzheimers disease (AD).

Supportive mentors were key, this scientist writes

Notice NOT-MH-21-305 from the NIH Guide for Grants and Contracts